Annual Total Assets
$36.73 M
-$31.92 M-46.50%
December 31, 2023
Summary
- As of February 7, 2025, ONCT annual total assets is $36.73 million, with the most recent change of -$31.92 million (-46.50%) on December 31, 2023.
- During the last 3 years, ONCT annual total assets has fallen by -$82.08 million (-69.09%).
- ONCT annual total assets is now -77.01% below its all-time high of $159.73 million, reached on December 31, 2007.
Performance
ONCT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$15.60 M
-$8.26 M-34.61%
September 30, 2024
Summary
- As of February 7, 2025, ONCT quarterly total assets is $15.60 million, with the most recent change of -$8.26 million (-34.61%) on September 30, 2024.
- Over the past year, ONCT quarterly total assets has dropped by -$13.54 million (-46.46%).
- ONCT quarterly total assets is now -90.23% below its all-time high of $159.73 million, reached on December 31, 2007.
Performance
ONCT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ONCT Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.5% | -46.5% |
| 3 y3 years | -69.1% | -73.2% |
| 5 y5 years | +17.3% | -73.2% |
ONCT Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.8% | at low | -83.3% | at low |
| 5 y | 5-year | -69.1% | +68.9% | -86.9% | at low |
| alltime | all time | -77.0% | +2088.9% | -90.2% | +19.9% |
Oncternal Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.60 M(-34.6%) |
| Jun 2024 | - | $23.86 M(-18.1%) |
| Mar 2024 | - | $29.14 M(-20.7%) |
| Dec 2023 | $36.73 M(-46.5%) | $36.73 M(-15.0%) |
| Sep 2023 | - | $43.20 M(-14.9%) |
| Jun 2023 | - | $50.77 M(-12.9%) |
| Mar 2023 | - | $58.28 M(-15.1%) |
| Dec 2022 | $68.65 M(-26.6%) | $68.65 M(-9.9%) |
| Sep 2022 | - | $76.17 M(-6.6%) |
| Jun 2022 | - | $81.53 M(-4.6%) |
| Mar 2022 | - | $85.49 M(-8.7%) |
| Dec 2021 | $93.58 M(-21.2%) | $93.58 M(-6.7%) |
| Sep 2021 | - | $100.30 M(-7.5%) |
| Jun 2021 | - | $108.42 M(-4.9%) |
| Mar 2021 | - | $114.06 M(-4.0%) |
| Dec 2020 | $118.81 M(+446.4%) | $118.81 M(+404.5%) |
| Sep 2020 | - | $23.55 M(+24.6%) |
| Jun 2020 | - | $18.90 M(+6.4%) |
| Mar 2020 | - | $17.77 M(-18.3%) |
| Dec 2019 | $21.74 M(-30.6%) | $21.74 M(-13.2%) |
| Sep 2019 | - | $25.05 M(-18.9%) |
| Jun 2019 | - | $30.90 M(+36.5%) |
| Mar 2019 | - | $22.64 M(-27.7%) |
| Dec 2018 | $31.32 M(-32.3%) | $31.32 M(-22.2%) |
| Sep 2018 | - | $40.27 M(-15.6%) |
| Jun 2018 | - | $47.72 M(+38.9%) |
| Mar 2018 | - | $34.36 M(-25.7%) |
| Dec 2017 | $46.24 M(+88.7%) | $46.24 M(-17.2%) |
| Sep 2017 | - | $55.85 M(+308.6%) |
| Jun 2017 | - | $13.67 M(-27.9%) |
| Mar 2017 | - | $18.94 M(-22.7%) |
| Dec 2016 | $24.50 M(-23.5%) | $24.50 M(+55.6%) |
| Sep 2016 | - | $15.75 M(-28.3%) |
| Jun 2016 | - | $21.98 M(-17.7%) |
| Mar 2016 | - | $26.70 M(-16.6%) |
| Dec 2015 | $32.03 M(-36.8%) | $32.03 M(-15.2%) |
| Sep 2015 | - | $37.78 M(-9.8%) |
| Jun 2015 | - | $41.86 M(-8.6%) |
| Mar 2015 | - | $45.78 M(-9.6%) |
| Dec 2014 | $50.65 M(+224.6%) | $50.65 M(+289.1%) |
| Sep 2014 | - | $13.02 M(-32.0%) |
| Jun 2014 | - | $19.14 M(-35.8%) |
| Mar 2014 | - | $29.79 M(+90.9%) |
| Dec 2013 | $15.61 M | $15.61 M(-30.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $22.49 M(-32.8%) |
| Jun 2013 | - | $33.49 M(-25.1%) |
| Mar 2013 | - | $44.70 M(-22.6%) |
| Dec 2012 | $57.77 M(-26.5%) | $57.77 M(-19.9%) |
| Sep 2012 | - | $72.17 M(+22.0%) |
| Jun 2012 | - | $59.15 M(-12.5%) |
| Mar 2012 | - | $67.61 M(-14.0%) |
| Dec 2011 | $78.66 M(+22.4%) | $78.66 M(-9.5%) |
| Sep 2011 | - | $86.91 M(-8.4%) |
| Jun 2011 | - | $94.83 M(+76.1%) |
| Mar 2011 | - | $53.86 M(-16.2%) |
| Dec 2010 | $64.25 M(+11.3%) | $64.25 M(+106.7%) |
| Sep 2010 | - | $31.08 M(-21.9%) |
| Jun 2010 | - | $39.78 M(-24.8%) |
| Mar 2010 | - | $52.87 M(-8.4%) |
| Dec 2009 | $57.72 M(-46.6%) | $57.72 M(-11.3%) |
| Sep 2009 | - | $65.06 M(-18.2%) |
| Jun 2009 | - | $79.53 M(-14.2%) |
| Mar 2009 | - | $92.67 M(-14.3%) |
| Dec 2008 | $108.11 M(-32.3%) | $108.11 M(-6.8%) |
| Sep 2008 | - | $116.00 M(-10.5%) |
| Jun 2008 | - | $129.58 M(-11.9%) |
| Mar 2008 | - | $147.08 M(-7.9%) |
| Dec 2007 | $159.73 M(+23.6%) | $159.73 M(+58.7%) |
| Sep 2007 | - | $100.65 M(-10.7%) |
| Jun 2007 | - | $112.73 M(-7.5%) |
| Mar 2007 | - | $121.90 M(-5.7%) |
| Dec 2006 | $129.25 M(+56.1%) | $129.25 M(+58.2%) |
| Sep 2006 | - | $81.73 M(+27.9%) |
| Jun 2006 | - | $63.92 M(-14.4%) |
| Mar 2006 | - | $74.71 M(-9.8%) |
| Dec 2005 | $82.81 M(+13.3%) | $82.81 M(+73.6%) |
| Sep 2005 | - | $47.69 M(-17.4%) |
| Jun 2005 | - | $57.73 M(-12.1%) |
| Mar 2005 | - | $65.67 M(-10.1%) |
| Dec 2004 | $73.08 M(+322.2%) | $73.08 M(-7.7%) |
| Sep 2004 | - | $79.16 M(-6.9%) |
| Jun 2004 | - | $85.04 M(-4.8%) |
| Mar 2004 | - | $89.32 M(+416.0%) |
| Dec 2003 | $17.31 M(+72.6%) | $17.31 M |
| Dec 2002 | $10.03 M(-0.9%) | - |
| Dec 2001 | $10.12 M(+216.1%) | - |
| Dec 2000 | $3.20 M(+90.8%) | - |
| Dec 1999 | $1.68 M | - |
FAQ
- What is Oncternal Therapeutics annual total assets?
- What is the all time high annual total assets for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual total assets year-on-year change?
- What is Oncternal Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly total assets year-on-year change?
What is Oncternal Therapeutics annual total assets?
The current annual total assets of ONCT is $36.73 M
What is the all time high annual total assets for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual total assets is $159.73 M
What is Oncternal Therapeutics annual total assets year-on-year change?
Over the past year, ONCT annual total assets has changed by -$31.92 M (-46.50%)
What is Oncternal Therapeutics quarterly total assets?
The current quarterly total assets of ONCT is $15.60 M
What is the all time high quarterly total assets for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly total assets is $159.73 M
What is Oncternal Therapeutics quarterly total assets year-on-year change?
Over the past year, ONCT quarterly total assets has changed by -$13.54 M (-46.46%)